UC San Diego Health is the First in the Region to Implant Dual Chamber, Leadless Pacemaker

UC San Diego Health Makes History with Implantation of Dual Chamber Leadless Pacemaker System for Arrhythmias

UC San Diego Health has made history by implanting the world’s first dual chamber and leadless pacemaker system to treat individuals with irregular heart rhythms, also known as arrhythmias. These conditions can lead to complications such as palpitations, fainting, and stroke. Atrial fibrillation, the most common type of arrhythmia, is expected to affect around 12.1 million people in the United States by 2030, according to estimates from the Centers for Disease Control and Prevention.

Pacemakers and implantable cardioverter defibrillators (ICDs) are typically used to regulate irregular heartbeats. The newly approved leadless pacemaker system, cleared by the U.S. Food and Drug Administration in July 2023, is placed in both chambers of the heart and utilizes innovative communication technology to provide a less invasive option for patients. UC San Diego Health performed the first implantation of this pacemaker system in a patient in February 2024.

Dr. Ulrika Birgersdotter-Green, a cardiologist and director of pacemaker and ICD services at UC San Diego Health, expressed excitement about the new technology, stating, “To have the option to use a leadless pacemaker system on both sides of the heart will allow us to treat more individuals currently living with heart arrhythmias.” Approximately 80% of patients who receive a pacemaker require a dual chamber option. While leadless pacemakers have been preferred by patients, they were previously only available for individuals needing pacing on one side of the heart. With this new technology, patients can now benefit from a more comprehensive treatment option that is less invasive and offers better outcomes than traditional pacemakers or ICDs.

Leave a Reply

March Madness Report Card: UConn Shines with ‘A+’ while Kentucky Falls Short with ‘F’ in Opening Weekend Previous post NCAA Tournament 2024: Who’s Standing Out in the Sweet 16 and Why?
Doctors Manojna Konda, M.D. and Vivek Yadala, M.D. become part of UAMS Baptist Health Cancer Network Next post Expanded Cancer Services at UAMS Baptist Health: Adding Top Medical Oncologists Enhances Patient Care